In clear cell renal cell carcinoma, S100A6 (Calcyclin), as an oncogenic protein, negatively regulates CXCL14 expression, and knockdown of S100A6 promotes CXCL14-mediated apoptosis and promotes tumour progression [38]. Here, CXCL14 is linked to neoplasm.